Skip to content

A study to evaluate the effects of Tomatis auditory stimulation compared with a sham device on brain function in healthy volunteers.

An investigator initiated, exploratory, randomized, double-blind, sham-controlled, post-marketing, non-significant risk audio device study to evaluate the mechanistic effects of Auditory Stimulation using the Tomatis (registered trademark) Maestro device on neurofunctional parameters in healthy human volunteers. - TOM-CR-2601

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107182
Enrollment
20
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Tomatis Maestro Device: The Tomatis Maestro headset is a specialised medical device that uses air and bone conduction to deliver processed music, believed to be effective for various

Sponsors

Tomatis Development SA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1. Healthy male or female volunteers of 20 to 40 years both inclusive with BMI of 18 35 Kgm2 2. Generally healthy as documented by medical history, physical examination, vital signs, and any available prior medical records. 3. Subjects who have no evidence of medical illness during screening.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1. Subjects with any ear infection or auditory issues during screening. 2. History of any clinically significant cardiac, gastrointestinal, respiratory, hepatic, renal, endocrine, neurological, metabolic, psychiatric, hematological and or any major surgical procedure in the past three months prior to screening. 3. Subjects with a history of epilepsy 4. History of chronic alcoholism, chronic smoking, drugs of abuse. 5. Subjects who cannot listen to music for an hour continuously every day for 14 days. 6. High blood pressure and or asthma. 7. Subject who had participated in any other clinical study during the last 90 days. 8. Subjects who are unable to provide informed consent 9. Subjects who are unable or unwilling to undergo MRI scanning 10. Subjects with metal implants, medical devices such as pacemakers or insulin pumps or tattoos as they cannot undergo MRI scans 11. Subjects who are unable or unwilling to comply with the requirements of the study 12. Pregnant women or Lactating mothers

Design outcomes

Primary

MeasureTime frame
To evaluate the difference between the active Tomatis Maestro device group and the sham control device group in the change from baseline to end-of-study in resting-state functional connectivity, as assessed using Independent Component Analysis (ICA) of resting-state functional magnetic resonance imaging (rs-fMRI) data.Timepoint: Before and after stimulation

Secondary

MeasureTime frame
1. To evaluate the difference between the active and sham device groups in changes from baseline to end-of-study in resting-state cortical oscillatory activity, as measured by quantitative electroencephalography (qEEG). 2. To evaluate changes in acoustic voice parameters following the intervention, using standardized voice analysis. 3. To evaluate changes in listening function using the Tomatis Fused Listening Test between baseline and end-of-study. 4. To evaluate changes in subjective vitality using the State version of the Subjective Vitality Scale (SVS) between baseline and end-of-study. 5. To evaluate changes in mindful attention and awareness using the Mindful Attention Awareness Scale (MAAS) between baseline and end-of-study. 6. To evaluate the safety and tolerability of the Tomatis Maestro auditory stimulation intervention.Timepoint: Before and after stimulation

Countries

India

Contacts

Public ContactAdarsh Karanth

ClinTrek Research Private Limited

adarsh@clintrek.com9866951573

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026